Skip to content
Screener

Repligen RGEN Net Income

Net Income at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.74B+7.4%
Danaher logo
DanaherDHR
$870M+56.8%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
-$3.73M+87.5%
Charles River Laboratories logo
Charles River LaboratoriesCRL
-$1.48M-103%
TEC
Bio-TechneTECH
$51.05M+126%
Revvity logo
RevvityRVTY
$40.72M-3.6%

Other financials

Income statement

See full
Revenue$204.1M+11.9%
Gross profit$110.0M+20.7%
Operating income$14.0M+0.6%
EPS (diluted)$0.09-65.4%

Balance sheet

See full
Cash & equivalents$606.8M-14.4%
Total debt$690.9M+354%
Total equity$2.1B+2.4%
Total assets$3.0B+1.7%

Cash flow

See full
Operating cash flow$32.8M+14.5%
CapEx$5.3M-24.9%
Free cash flow$27.4M+27.5%

Valuation

See full
Market cap$8.95B+42.1%
Enterprise value$9.03B+57.3%
P/E215.5×
P/S11.6×+0.3×

Profitability

See full
Gross margin47.6%+0.9pp
Operating margin15.6%-11.0pp
Net margin17.3%-3.5pp
FCF margin22%+6.9pp

Returns & leverage

See full
Return on equity2%+1.6pp
Debt / equity0.3×+0.3×
Current ratio9.1×+0.5×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Repligen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323773
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other income (expense), net1774,319(13,991)5,684
Income before income taxes14,15318,21515,92526,158
Income tax provision9,1453,3492,5845,462
Net income$5,008$14,866$13,341$20,696
Earnings per share:
Basic$0.09$0.26$0.24$0.37
Diluted$0.09$0.26$0.24$0.37
Weighted average common shares outstanding:

ITEM 1. Financial Statements

FAQ

What is Repligen's net income?
Repligen (RGEN) reported net income of $5.01M in Q2 2026.
How has Repligen's net income changed year-over-year?
Repligen's net income decreased by 66.3% year-over-year, from $14.87M to $5.01M.
What is the long-term trend for Repligen's net income?
Over 3 years (2021 to 2025), Repligen's net income has grown at a -27.5% compound annual growth rate (CAGR), from $128.29M to $48.89M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about Repligen's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude